PBPK modeling for irbesartan in different CYP2C9 genotypes

被引：0
|
作者：
Kang, Pureum [1 ]
Cho, Chang-Keun [1 ]
Ko, Eunvin [1 ]
Mu, Chou Yen [1 ]
Lee, Seok-Yong [1 ]
机构：
[1] Sungkyunkwan Univ, Seoul, South Korea
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0064
引用
收藏
页码：249 / 250
页数：2
相关论文
共 50 条
  • [21] Enzymatic activity of 38 CYP2C9 genotypes on ibuprofen
    Yuan, Ling-jing
    Li, Xiang-yu
    Ye, Feng
    Li, Xin-yue
    Li, Qing-qing
    Zhong, Yun-shan
    Wang, Shi-yu
    Wang, Ya-hui
    Hu, Guo-xin
    Cai, Jian-ping
    Li, Jun-wei
    FOOD AND CHEMICAL TOXICOLOGY, 2023, 178
  • [22] Influence of CYP2C9 genotypes on the pharmacokinetics and pharmacodynamics of piroxicam
    Perini, JA
    Vianna-Jorge, R
    Brogliato, AR
    Suarez-Kurtz, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (04) : 362 - 369
  • [23] Role of CYP2C9 and its variants (CYP2C9*3 and CYP2C9*13) in the metabolism of lornoxicam in humans
    Guo, YJ
    Zhang, YF
    Wang, Y
    Chen, XY
    Si, DY
    Zhong, DF
    Fawcett, JP
    Zhou, H
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (06) : 749 - 753
  • [24] Kinetic analysis of fluvastatin metabolism by CYP2C9 and its allelic variants, CYP2C9*2 and CYP2C9*3
    Einolf, HJ
    Fischer, V
    DRUG METABOLISM REVIEWS, 2003, 35 : 191 - 191
  • [25] Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism
    Young-Hoon Kim
    Pureum Kang
    Chang‑Keun Cho
    Eui Hyun Jung
    Hye-Jeong Park
    Yun Jeong Lee
    Jung‑Woo Bae
    Choon-Gon Jang
    Seok-Yong Lee
    Archives of Pharmacal Research, 2021, 44 : 713 - 724
  • [26] The role of CYP2C8 and CYP2C9 genotypes in acute myocardial infarction
    Yasar, Ü
    Bennet, A
    Eliasson, E
    Lundgren, S
    Wiman, B
    de Faire, U
    Rane, A
    DRUG METABOLISM REVIEWS, 2003, 35 : 132 - 132
  • [27] Catalytic roles of CYP2C9 and its variants (CYP2C9*2 and CYP2C9*3) in lornoxicam 5′-hydroxylation
    Iida, I
    Miyata, A
    Arai, M
    Hirota, M
    Akimoto, M
    Higuchi, S
    Kobayashi, K
    Chiba, K
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (01) : 7 - 9
  • [28] Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism
    Kim, Young-Hoon
    Kang, Pureum
    Cho, Chang-Keun
    Jung, Eui Hyun
    Park, Hye-Jeong
    Lee, Yun Jeong
    Bae, Jung-Woo
    Jang, Choon-Gon
    Lee, Seok-Yong
    ARCHIVES OF PHARMACAL RESEARCH, 2021, 44 (07) : 713 - 724
  • [29] CYP2C9*3 allelic variant is associated with metabolism of irbesartan in Chinese population
    Hong, XM
    Zhang, SC
    Mao, GY
    Jiang, SQ
    Zhang, Y
    Yu, YX
    Tang, GF
    Xing, HX
    Xu, XP
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 627 - 634
  • [30] Safety of voriconazole in a patient with CYP2C9*2/CYP2C9*2 genotype
    Geist, Marcus J. P.
    Egerer, Gerlinde
    Burhenne, Juergen
    Mikus, Gerd
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (09) : 3227 - 3228
12345